SVP Clinical Development & Global Program Lead, Lung Cancer
Erasca is a clinical-stage precision oncology company focused on discovering, developing and commercializing medicines for the benefit of patients with cancer. Our programs take novel approaches to shutting down one of cancer’s most commonly mutated signaling cascades, the RAS/MAPK pathway, which affects approximately 5.5 million lives each year worldwide. The name “Erasca” has an important embedded meaning: it is a contraction of our audacious hope to “erase cancer” that drives our mission and everything that we do on behalf of patients with cancer.
Reporting to the Chief Medical Officer, the VP Clinical Development and Global Program Lead (GPL) for Lung Cancer will provide medical leadership and oversight of the lung cancer development program and collaborate with the CMO across the Erasca portfolio. Responsibilities will include clinical development strategy,
